<?xml version="1.0" encoding="UTF-8"?>
<p id="Par52">
 <list list-type="bullet">
  <list-item>
   <p id="Par53">Time to change or cessation of systemic therapy (AI + CDK 4/6 inhibitor), defined as the time from commencement of SRT to change in systemic therapy due to any of the following events: 
    <list list-type="alpha-lower">
     <list-item>
      <p id="Par54">Clinically symptomatic progression requiring tumour specific palliative intervention e.g. change or cessation of anti-cancer systemic treatment, palliative radiotherapy as determined by treating doctor.</p>
     </list-item>
     <list-item>
      <p id="Par55">Development of new lesions or progression of existing lesions such that they do not meet the criteria for SRT.</p>
     </list-item>
     <list-item>
      <p id="Par56">Development of &gt; 3 new or progressing lesions.</p>
     </list-item>
     <list-item>
      <p id="Par57">Cessation of either agent (AI + CDK 4/6 inhibitor) for more than 1 month due to any cause.</p>
     </list-item>
     <list-item>
      <p id="Par58">Development of progression in less than 6 months.</p>
     </list-item>
    </list>
   </p>
  </list-item>
 </list>
</p>
